Accelerating Progress in
Anti-Aging Medicine Research
|
LIVES™
The MaxLife Accelerator Fund utilizes the financial strategy known as LIVES™. This preferred strategy will finance the research needed to profitably develop life extending technologies. LIVES™ offers investors all of the following benefits:
- Liquidity. Invested funds or “deposits” are redeemable, much like a bank CD.
- Income. Depositors earn 6% projected annual dividends.
- Venture capital returns. Depositors earn a projected annual internal rate of return (IRR) of 27% over the 10 year life of the fund plus residuals from the 11th–17th years.
- Equity. Depositors get positions in potentially some of the world’s bigger and more profitable companies. The projected IRR does not reflect this potentiality.
- Safety. Your deposits are never exposed to more than a 10% drawdown.
Compared with popular investment vehicles, LIVES™ not only shines in each illustrated category, but it also offers the potential to ultimately save up to 37 million lives per year.
| LIVES™ CMO’s | LIVES™ Bonds | S&P 500 | Hedge Funds | 20 Year T-Bonds | Futures | Venture Capital | |
| Liquidity | Yes | Yes | Yes | Yes | Yes | Yes | No |
| Income | Yes | Yes | No | No | Yes | No | No |
| Predictable Cash Flow | Yes | Yes | No | No | Yes | No | No |
| Annual Return | 27%* | 24%* | 11.3%* | 14.8*** | 5.3%**** | 6.3%***** | 21% |
| Largest Annual Drawdown | <10% | <5% | 64%** | 11.4%*** | 13.3%**** | 17.7%***** | N/A |
*Projected. Assumptions will be proven with documented personal presentation to your due diligence team.
**64% in 1932. 35% in 1937, 34% in 1974 and 40% in 2002
***Hedge Fund Research Index 1990-2005
****1926-1999
*****Managed Futures Index 1994-2005
Click here for information on the MaxLife Accelerator Fund
Back to Top